EP3661514
MAVACAMTEN FOR USE IN THE TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
3.8.2018:
17.9.2025:
18759209.2
:
2.8.2038:
2.8.2026
:
MAVACAMTEN FOR USE IN THE TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY
3.8.2018
17.9.2025
2.8.2026
:
MyoKardia, Inc.:
1000 Sierra Point Parkway, Brisbane, CA 94005, US
:
SEMIGRAN, Marc J.:
Brisbane, CA 94005, US
:
LEE, June H.:
Brisbane, CA 94005, US
:
LAMBING, Joseph:
Brisbane, CA 94005, US
:
GREEN, Eric:
Brisbane, CA 94005, US
:
EVANCHIK, Marc:
Brisbane, CA 94005, US
:
CARLSON, Timothy:
Belmont, CA 94002, US
:
ZHANG, David:
San Carlos, CA 94070, US
:
201762541591 P:
4.8.2017:
US
:
201762584537 P:
10.11.2017:
US
:
201862639922 P:
7.3.2018:
US
:
201862671585 P:
15.5.2018:
US
:
US2018045180:
3.8.2018
:
A61K 31/513, A61P 9/04, A61P 9/10